Related Experiment Video
Updated: Jan 24, 2026

Standardized Modular Assembly of Polycistronic Operons with Modular Cloning (MoClo) using the In-Cloning toolkit
Published on: September 2, 2025
The Use of Bayesian Hierarchical Logistic Regression in the Development of a Modular Viral Inactivation Claim
Dwaine Banton1, Dominick Vacante1, Ben Bulthuis1
1Janssen R and D, 200 Great Valley Parkway, Malvern, PA 19355.
Bayesian hierarchical logistic regression modeling enhances viral inactivation claims for biopharmaceutical manufacturing. This approach provides probabilistic characterization of log10 reduction values (LRVs) for low pH inactivation, improving decision-making.
Area of Science:
- Biopharmaceutical Manufacturing
- Viral Clearance
- Statistical Modeling
Background:
- Low pH inactivation is a standard method for enveloped virus removal in biopharmaceutical production.
- Current statistical methods for viral inactivation claims often lack probabilistic characterization of log10 reduction values (LRVs).
- Existing analyses struggle to incorporate historical data and right-censored data effectively.
Purpose of the Study:
- To introduce a novel statistical approach for evaluating low pH viral inactivation.
- To enable probabilistic characterization of future experimental LRVs.
- To support the development of modular viral clearance claims for biopharmaceutical manufacturing.
Main Methods:
- Bayesian hierarchical logistic regression modeling was employed.
- The model accommodates historical data from diverse experiments.
- The method handles right-censored data, a common challenge in inactivation studies.
Main Results:
- The Bayesian approach allows for probability statements on successful viral inactivation based on process parameters.
- This facilitates the creation of modular claims for viral clearance, ensuring a critical LRV.
- The risk-based approach, combined with descriptive statistics, aids in coherent decision-making for LRV claims.
Conclusions:
- Bayesian modeling offers a more robust statistical framework for viral inactivation validation.
- This methodology enhances the reliability of modular viral clearance claims.
- The approach supports efficient and scientifically sound biopharmaceutical development.
Related Concept Videos
X-Inactivation
Regression Toward the Mean
Testing a Claim about Mean: Known Population SD
Estimating a population mean requires the samples to be distributed normally. The data should be collected from the randomly selected samples having no sampling bias. The sample size needed to be higher than 30, and most importantly, the population standard deviation should be already known.
In most realistic situations, the population standard deviation is often unknown, but in rare circumstances, when it...
Multiple Regression
Farmers can use multiple regression to determine the crop yield based on more than one factor, such as water availability, fertilizer, soil properties, etc. Here, the crop yield is the response or dependent variable as it depends on the other independent variables. The analysis requires the construction of a scatter plot...
Testing a Claim about Population Proportion
There are two methods of testing a claim about a population proportion: (1) Using the sample proportion from the data where a binomial distribution is approximated to the normal distribution and (2) Using the binomial probabilities calculated from the data.
The first method uses normal distribution as an approximation to the binomial distribution. The requirements are as follows: sample size is large...
Testing a Claim about Standard Deviation
The hypothesis testing for the claim of population standard deviation (or variance) requires the data and samples to be random and unbiased. The population distribution also must be normal. There is no specific requirement on the sample size as the estimation is based on the chi-square distribution.
As a first step, the hypothesis (null and alternative) concerning the claim about...

